PreDxion Bio
Rapid, scalable diagnostic for SARS-CoV-2 and beyond
What they do
Public health and clinicians lack a rapid, scalable way to detect SARS-CoV-2 (and monitor key immune biomarkers) to enable timely screening and patient management.
A rapid saliva-based antigen test and semiconductor-fabricated sensor platform for near real-time detection of SARS-CoV-2 S-protein and other cytokines/biomarkers.
Public health agencies, healthcare providers, and clinical labs needing high-volume screening and immune-response monitoring.
Founders
Walker is Co-founder and CEO of PreDxion Bio. Walker is a graduate of the University of Michigan, completing undergraduate studies in immunology and further graduate training in the Medical Product Development Program at the University of Michigan College of Engineering. Walker is a past Fellow in the Zell Global Entrepreneurship Program, was named the 2017 University of Michigan Graduate Student Entrepreneur of the Year, and a Top 20 Entrepreneur Alumni from the University of Michigan in 2019.
Company timeline
- Founded2017
- YC batchSummer 2017
- StatusInactive
- Team size6 people
- LocationSouth San Francisco, CA, USA
Similar startups
